The Canadian federal government has launched a new risk assessment for AquaBounty’s new genetically modified (GM) salmon, following the company’s July 2018 announcement that it planned to build a new egg production and grow-out facility in Rollo Bay West, Prince Edward Island (PEI), according to Environment and Climate Change Canada (ECCC).
The Food and Drug Administration (FDA) is facing a lawsuit filed by nearly a dozen fishing and environmental groups that are trying to block the agency’s recent approval of genetically modified salmon.
Months after the Food and Drug Administration (FDA) approved the nation’s first genetically modified (GM) salmon for human consumption, the agency has issued a ban on the import and sale of the fish until health regulators can publish guidelines for how it should be labeled. [1]
In the massive spending bill unveiled Wednesday morning on Capitol Hill, 2 small paragraphs contain language that may force the U.S. Food and Drug Administration (FDA) to finalize guidelines for the labeling of the recently-approved genetically modified (GM) salmon, or “Frankenfish.”
